Identification of <i>ROS1</i> rearrangement in gastric adenocarcinoma

Abstract

In this study, an SLC34A2-ROS1 rearrangement was identified in GC, and the results provide a rationale for investigating the clinical efficacy of ROS1 inhibitors in this unique molecular subset of GC. Society.